Johnson & Johnson Raises 2024 Guidance Following Acquisition of Shockwave Medical

1. Acquisition of Shockwave Medical: Johnson & Johnson (J&J) has agreed to acquire Shockwave Medical for $13.1 billion, expanding its medical device portfolio.
2. Raised 2024 Guidance: Following the acquisition, J&J has updated its 2024 guidance, reflecting the potential of Shockwave Medical's technology.
3. Billion-Dollar Potential: The acquisition is expected to contribute significantly to J&J's revenue, with Shockwave Medical's device having billion-dollar potential.
4. Improved Guidance: The updated guidance includes adjusted operational EPS guidance, indicating a positive outlook for J&J's performance in 2024.